SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo Us Bio Tech informs about closure of trading window

29 Jun 2026 Evaluate
Indo Us Bio Tech has informed that in terms of Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company, pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, read with BSE vide circular no. LIST/COMP/01/2019- 20 dated 2nd April, 2019, the Trading Window for dealing in the Securities of the Company will remain closed from Wednesday, 1st July, 2026 till 48 hours after announcement / declaration of Unaudited financial results for the quarter ended on 30th June, 2026.

The above information is a part of company’s filings submitted to BSE.

Indo US Bio-Tech Share Price

88.90 1.90 (2.18%)
01-Jul-2026 13:17 View Price Chart
Peers
Company Name CMP
Venkys (India) 1420.00
Mangalam Global Ent. 16.52
Kaveri Seed 891.05
Regaal Resources 79.00
Simran Farms 157.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: